Literature DB >> 11502047

Changes in the occurrence of mechanical alternans after long-term beta-blocker therapy in patients with chronic heart failure.

M Kodama1, K Kato, S Hirono, H Hanawa, Y Okura, M Ito, K Fuse, T Shiono, H Tachikawa, M Hayashi, S Abe, T Yoshida, Y Aizawa.   

Abstract

Mechanical alternans has been observed in patients with severe congestive heart failure, and the phenomenon is considered to be a terminal sign. Therapeutic strategies for chronic heart failure have significantly developed, but it is uncertain whether patients with mechanical alternans can be effectively treated or not. Seventeen consecutive patients with dilated cardiomyopathy were enrolled: 11 were treated with beta-blockers on conventional therapeutic regimens and 6 patients were not indicated for or were unable to continue beta-blockade. Mechanical alternans was detected during cardiac catheterization in the patients under physiologic tachycardia (110 beats/min) and stepwise dobutamine loading. In the initial study, mechanical alternans occurred in 70.6% of the patients: 8 of the 11 being treated with beta-blockers and 4 of the 6 without beta-blockade therapy. In the second study, none of the patients taking beta-blockers showed mechanical alternans under the same protocol; the occurrence of mechanical alternans did not change in the patients who were not being treated with beta-blockers. The left ventricular ejection fraction increased in patients whose mechanical alternans could not be induced during the follow up, but decreased in the patients in whom mechanical alternans was repeatedly inducible. It is concluded that mechanical alternans is associated with the failing myocardium and may be potentially correctable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502047     DOI: 10.1253/jcj.65.711

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  1 in total

1.  Mechanical alternans in human idiopathic dilated cardiomyopathy is caused with impaired force-frequency relationship and enhanced poststimulation potentiation.

Authors:  Takeshi Kashimura; Makoto Kodama; Komei Tanaka; Keiko Sonoda; Satoru Watanabe; Yukako Ohno; Makoto Tomita; Hiroaki Obata; Wataru Mitsuma; Masahiro Ito; Satoru Hirono; Haruo Hanawa; Yoshifusa Aizawa
Journal:  Heart Vessels       Date:  2012-05-10       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.